StockNews.AI
ELV
StockNews.AI
222 days

Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025

1. Elevance Health will announce Q4 and FY 2024 results on January 23, 2025. 2. A conference call will follow the financial results release on the same day. 3. Upcoming results may influence market perception and stock valuation of ELV significantly.

7m saved
Insight
Article

FAQ

Why Bullish?

Strong financial results typically attract investor interest, positively impacting stock prices.

How important is it?

The earnings announcement is crucial for assessing ELV's financial health and growth trajectory.

Why Short Term?

Immediate market reactions expected post-conference call based on performance announcements.

Related Companies

Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025

INDIANAPOLIS--( )--Elevance Health (NYSE: ELV) will release fourth quarter and full year 2024 financial results on January 23, 2025, at 6:00 a.m. Eastern Standard Time (“EST”). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

  • 888-947-9963 – Access Code - 3972058 (Domestic)
  • 312-470-0178 – Access Code - 3972058 (International)
  • 866-405-7292 – No Access Code (Domestic Replay)
  • 203-369-0604 – No Access Code (International Replay)

The replay will be available from 11:30 a.m. EST on January 23, 2025, until the end of the day on February 21, 2025. The call will also be available through a live webcast at www.elevancehealth.com under the “Investors” link. You may also access the webcast here. A webcast replay will be available following the call.

About Elevance Health

Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey – connecting them to the care, support, and resources they need to lead better lives. Elevance Health’s companies serve approximately 113 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on X and Elevance Health on LinkedIn.

Contacts

Investor Relations:
Nathan Rich
Investor.Relations@elevancehealth.com         

Media Relations:
Leslie Porras
Leslie.Porras@elevancehealth.com

Related News